window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CDMO

  • CDMOs & Manufacturing,Facilities and infrastructure,Supply Chain & Logistics

    Symbiosis receives King’s Award for Enterprise recognising international growth

    Symbiosis Pharmaceutical Services has been formally presented with a 2025 [...]

    November 26, 2025
  • Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,European biotech,Pharmaceuticals and therapeutics

    Cytovance Biologics celebrates 20 years advancing biopharma manufacturing in Oklahoma City

    Cytovance Biologics, a contract development and manufacturing organisation serving the [...]

    November 14, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Partnerships & Funding,Technology and platforms

    Lonza to acquire Redberry to expand rapid microbiology testing for pharmaceutical quality control

    Lonza has signed an agreement to acquire Redberry, a French [...]

    November 6, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Clinical studies,Market Access & Commercialization

    KBI Biopharma CBO Katie Edgar on ADCs, biologics, and digital innovation in drug development

    Discover Pharma caught up with Katie Edgar, chief business officer [...]

    November 13, 2025
  • Artificial Intelligence,Biotech,CDMOs & Manufacturing

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    November 6, 2025
  • Biologics & Biosimilars,Biomanufacturing,Biotech,CDMOs & Manufacturing,Clinical Development,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    November 5, 2025
  • Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CDMO Argonaut appoints Rick Hancock to drive next phase of biologics and commercial manufacturing

    Argonaut Manufacturing Services has named Rick Hancock as chief executive [...]

    November 5, 2025
  • Biomanufacturing,Biotech,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics

    BBG Advanced Therapies and CELLforCURE partner to provide transatlantic ATMP manufacturing solutions

    BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

    October 7, 2025
  • Biomanufacturing,CDMOs & Manufacturing,Cell & Gene Therapy,Clinical Development,Drug Development,Pharmaceuticals and therapeutics,Technology and platforms

    ReiThera: Commercial CDMO capabilities key to manage ‘volatile’ biotech market

    ReiThera will begin commercial production in 2026, a milestone the [...]

    September 25, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Pharmaceuticals and therapeutics,Technology and platforms

    RION partners with Lonza to scale manufacturing of exosome-based therapeutics

    RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

    September 23, 2025
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion
    Categories: Drug discovery, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Precision medicine, Research & Development, Technology and platforms
  • Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow
    Categories: Biomanufacturing, CDMOs & Manufacturing, Drug Development, Manufacturing, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • Emalex wins US patent for ecopipam ODT as Tourette access program grows
    Categories: Clinical Development, Drug Development, FDA, Neurosciences, Pharmaceuticals and therapeutics, Rare Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top